Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is ...

Bionano (BNGO) Q3 2025 Earnings Call Transcript

Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call Transcript

Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...

GeoVax outlines expedited GEO-MVA clinical trial and global partnership strategy for 2025-2026

Discover key insights from GeoVax Labs’ Q3 2025 earnings call—expedited vaccine trials, partnership updates & clinical progress.

Blood Group Typing Global Market Overview 2025-2030: PCR-based Techniques Command the Largest Share

Major market opportunities in blood group typing include advancements in PCR and NGS technologies, growing demand for ...
Le Lézard

Direct-to-Consumer (DTC) Genetic Testing Market Set to Reach US$5.1 Billion by 2032 - Predictive Testing Dominates with 33.2% Share; Nutrigenomics Testing Poised for Fastest ...

Genetic Testing Market - Test Types, Technologies and Distribution Channels" has been added to ResearchAndMarkets.com's offering. The global DTC genetic testing market is heading for significant ...